Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Retinal Research Institute /ID# 256019

Phoenix, Arizona 85053, United StatesNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Macular degeneration

Running trials

Active, not recruiting
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
NCT04704921· Phase 2/3· AbbVie· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Retinal Research Institute /ID# 256019: trial site – Frontlight Research